|
June 2020 COVID-19 AND CARDIOVASCULAR CARE DURING THE COVID-19 PANDEMICFeaturing: Clyde W. Yancy, MD, MSc
Episode SummaryClyde W. Yancy, MD, MSc, discusses the increased risk faced by patients with COVID-19 and cardiovascular disease, COVID-19 as it relates to ACE inhibitors and ARBs, racial disparity in COVID-19 cases, and other topics related to treating cardiovascular patients during the COVID-19 pandemic.
|
Clyde W. Yancy, MD, MSc is a cardiologist and chief of the division of cardiology at Northwestern Memorial Hospital, and a past president of the American Heart Association.
Dr. Yancy has received recognition for clinical and research expertise in the field of heart failure and has additional interests in cardiomyopathy, heart valve diseases, hypertension, and prevention. He is also associate director of Northwestern Medicine Bluhm Cardiovascular Institute, and is the Magerstadt Professor of Medicine, professor of medical social sciences, and vice-dean of diversity and inclusion at Northwestern University Feinberg School of Medicine. Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|
You May Also Like
|
|
|